Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Annals of Surgical Oncology|August 23, 2014
A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusionGeorgia M Beasley, Paul Speicher, Christina K Augustine, et al.Journal of Women'S Health (2002)|December 4, 2008
Active Mothers Postpartum (AMP): rationale, design, and baseline characteristicsTruls Østbye, Katrina M Krause, Rebecca J N Brouwer, et al.Contemporary Clinical Trials|February 9, 2011
Kids and adults now! Defeat Obesity (KAN-DO): rationale, design and baseline characteristicsTruls Ostbye, Nancy L Zucker, Katrina M Krause, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 20, 2016
Efficacy of a Nurse-Delivered Intervention to Prevent and Delay Postpartum Return to Smoking: The Quit for Two TrialKathryn I Pollak, Laura J Fish, Pauline Lyna, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 22, 2006
Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trialKathryn I Pollak, Cheryl A Oncken, Isaac M Lipkus, et al.Leukemia & Lymphoma|September 4, 2008
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemiaArati V Rao, Islam R Younis, Gregory J Sand, et al.American Journal of Preventive Medicine|September 25, 2007
Nicotine replacement and behavioral therapy for smoking cessation in pregnancyKathryn I Pollak, Cheryl A Oncken, Isaac M Lipkus, et al.Preventive Medicine|June 19, 2012
Parent-focused change to prevent obesity in preschoolers: results from the KAN-DO studyTruls Østbye, Katrina M Krause, Marissa Stroo, et al.Cancer Chemotherapy and Pharmacology|July 12, 2002
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup studyRobert E Martell, Bercedis L Peterson, Harvey Jay Cohen, et al.International Journal of Oncology|June 18, 2004
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.Pageof 7